Position in KYMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,265,507
+$6,656,293 QoQ
Shares Held
229,053
-2.7% QoQ
Ownership
0.275%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#50
of 273 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GILDER GAGNON HOWE & CO LLC holds $353,222,516 across 21 Biotechnology names. KYMR ranks #6 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
269,051 | $80,992,422 | |
| 2 | NKTR |
Nektar Therapeutics
|
600,873 | $41,946,944 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
548,926 | $40,884,008 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,313,211 | $34,432,392 | |
| 5 | CYTK |
Cytokinetics Inc
|
400,245 | $34,096,871 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
This page
|
229,053 | $26,265,507 | |
| 7 | QURE |
uniQure N.V.
|
530,979 | $24,456,892 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
28,573 | $15,342,272 |
All Filings in KYMR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,265,507 | 229,053 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,609,214 | 235,433 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,667,863 | 239,916 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,963,446 | 246,704 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,358,432 | 329,020 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,714,087 | 318,381 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,129,020 | 326,349 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,789,122 | 291,340 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,902,260 | 130,729 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,346,157 | 132,989 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $1,137,923 | 81,865 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,039,948 | 88,732 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,651,766 | 89,496 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,251,042 | 90,186 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,767,593 | 81,194 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,871,987 | 95,073 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,845,893 | 114,506 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,615,815 | 119,953 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,735,705 | 131,694 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,266,033 | 108,578 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||